Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

The Journal of antimicrobial chemotherapy·2026
Same author

Characterization and host range associating factors of Staphylococcus aureus bacteriophage PBSA08; Using Australian MRSA reference set.

International journal of antimicrobial agents·2026
Same author

Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Direct Oral Challenge for Penicillin Allergy: A Hospital Implementation Evaluation Via the International Network of Antibiotic Allergy Nations (iNAAN) Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

In vitro activity of recently introduced Gram-positive-specific antimicrobial agents against Australian methicillin-resistant Staphylococcus aureus isolates.

Pathology·2026
Same author

Immune Responses to Phage Therapy in Humans: A Review.

The Journal of infectious diseases·2026
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
09:40

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins

Published on: June 11, 2015

12.2K

Therapeutic Phage Monitoring: A Review.

Kiran Bosco1,2, Stephanie Lynch1,2, Indy Sandaradura1,2,3,4

  • 1Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|November 6, 2023
PubMed
Summary
This summary is machine-generated.

Therapeutic phage monitoring (TPM) is crucial for optimizing phage therapy (PT) by tracking phage levels and immune responses. This approach enhances understanding of phage-bacteria interactions and improves patient care in the face of antimicrobial resistance.

Keywords:
bacteriabacteriophageinfectious disease‌phage therapytherapeutic phage monitoring

More Related Videos

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.0K
Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

1.9K

Related Experiment Videos

Last Updated: Jul 11, 2025

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
09:40

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins

Published on: June 11, 2015

12.2K
Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.0K
Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

1.9K

Area of Science:

  • Microbiology
  • Immunology
  • Pharmacology

Background:

  • Growing antimicrobial resistance necessitates novel treatment strategies.
  • Phage therapy (PT) shows promise for treating bacterial infections.
  • Knowledge gaps exist regarding PT's in vivo efficacy and host response.

Approach:

  • Propose Therapeutic Phage Monitoring (TPM) as a key component of PT protocols.
  • Monitor phage concentrations in blood and tissues.
  • Track patient immune responses and ecological changes during PT.

Key Points:

  • TPM enables optimization of phage dosing and precision medicine.
  • It validates diagnostic surrogates and establishes quality assurance for phage products.
  • TPM enhances understanding of phage-bacteria-host interactions.

Conclusions:

  • TPM is essential for advancing phage therapy research and application.
  • Implementing TPM can lead to improved patient outcomes.
  • This monitoring strategy supports the development of best practices in PT.